Notably, small molecules inhibitors of PDGFRβ have been reported to augment tumor immunity by depletion of FoxP3-expressing Tregs and increase in CD8+ T cells in humans and advanced tumor-bearing mice [72–74]. Here, PDGFRB is linked to neoplasm.